• Cengild Medical will hold its sixth annual general meeting on November 27, 2026, at Cengild Specialist Hospital in Kuala Lumpur.
• Shareholders will vote on renewing authority to issue shares capped at 10% of issued shares, excluding treasury shares, over 12 months.
• Another proposal would renew the mandate for recurrent related-party transactions of a revenue or trading nature.
• Directors’ fees and benefits of up to RM 200,000 for the period between this AGM and the next require shareholder approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cengild Medical Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3719498) on October 28, 2026, and is solely responsible for the information contained therein.